Fibrinolytic system activation immediately following trauma was quickly and intensely suppressed in a rat model of severe blunt trauma

Sci Rep. 2021 Oct 13;11(1):20283. doi: 10.1038/s41598-021-99426-2.

Abstract

In severe trauma, excessive fibrinolytic activation is associated with an increase in the transfusion volume and mortality rate. However, in the first several hours after a blunt trauma, changes in fibrinolytic activation, suppression, and activation-suppression balance have not yet been elucidated, which the present study aimed to clarify. Anesthetized 9-week-old male Wistar S/T rats experienced severe blunt trauma while being placed inside the Noble-Collip drum. Rats were randomly divided into four groups of seven. The no-trauma group was not exposed to any trauma; the remaining groups were analysed 0, 60, and 180 min after trauma. Immediately following trauma, total tissue-plasminogen activator (tPA) levels significantly increased in the plasma, and the balance of active tPA and active plasminogen activator inhibitor-1 (PAI-1) significantly tipped toward fibrinolytic activation. After trauma, both tPA and PAI-1 levels increased gradually in various organs and active and total PAI-1 levels increased exponentially in the plasma. Total plasma tPA levels 60 min after trauma returned quickly to levels comparable to those in the no-trauma group. In conclusion, fibrinolytic activation was observed only immediately following trauma. Therefore, immediately after trauma, the fibrinolytic system was activated; however, its activation was quickly and intensely suppressed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Gas Analysis
  • Blood Transfusion
  • Fibrinolysis*
  • Head Injuries, Closed / blood*
  • Head Injuries, Closed / physiopathology*
  • Male
  • Plasma
  • Plasminogen Activator Inhibitor 1 / blood
  • Rats
  • Rats, Wistar
  • Time Factors
  • Tissue Plasminogen Activator / biosynthesis
  • Wounds, Nonpenetrating

Substances

  • Plasminogen Activator Inhibitor 1
  • Tissue Plasminogen Activator